Published: 2021-04-13 14:39
Last Updated: 2021-05-06 10:12
Tuesday, US regulators recommended halting use of the Johnson & Johnson vaccine due to blood clotting concerns.
“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention (CDC).
“COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”
Six cases of blood clotting were reported in women ages 18-48.
The European Medicines Agency is investigating a similar issue.
This is a developing story.